Swiss Rockets AG to Acquire Complete Genomics

Complete Genomics entered into a definitive agreement to be acquired by Swiss Rockets AG, subject to customary closing conditions and approval by MGI shareholders. Swiss Rockets will own 100% of Complete Genomics and have sole control, while Complete Genomics continues operating as a U.S.-based company with its management team retaining responsibility for day-to-day operations and customer relationships.